Le Lézard
Classified in: Science and technology
Subjects: Conference, Event, Product/Service, Award

Outcomes Honors Achievements in Pharmacy Operations and Clinical Excellence at 2024 SYNC Outcomes National Conference


Outcomes®, a leading provider of integrated pharmacy workflow and patient engagement solutions linking pharmacy, payer and pharmaceutical ecosystems, announced the recipients of its first annual Excellence Awards at the annual SYNC Outcomes National Conference, held February 22-24 in Orlando.

The awards honor high-achieving pharmacies, payers and partners for operational and clinical excellence with 95% of clinical medication therapy management (MTM) opportunities successfully completed for 2023. Organizations recognized for excellence in 2023 include:

Top Retail Pharmacy
West Reading Drug Store

Chain Clinical Excellence
Albertsons

Top Chain Pharmacy
Kinney Drugs

Top Payer Partner
Humana

Top Pharma Partner
GSK

Top Third-Party Partner
Worldpay

Top Pharmacy Services Administration Organization (PSAO)
Elevate Provider Network

Most Innovative
Walgreens

In its inaugural year, the Outcomes SYNC National Conference brought together hundreds of leaders from world-class retail and chain pharmacies?as well as health plans and other stakeholders?to share best practices and help stakeholders strategically position for current and future challenges and opportunities.

"From changes with direct and indirect remuneration (DIR) fees to the expansion of Medicare Advantage MTM eligibility, pharmacies and their healthcare stakeholder partners face significant changes in 2024 and need partners to help navigate coming challenges. Outcomes is the only solutions company bringing pharmacies, payers and pharmaceutical manufacturers together to solve big problems," says Jude Dieterman, Chief Executive Officer of Outcomes. "These award winners have dedicated time and effort into transforming their businesses and operations in a forward-looking way. We're thrilled to call them partners."

About Outcomes

Outcomes® is the leader in integrated pharmacy workflow and patient engagement solutions for pharmacies, providers, payers and pharmaceutical companies. By uniting technology and clinical relationships through a connected healthcare network of 48,000 community, chain and grocery pharmacies, Outcomes delivers access and quality care to more than 70 million patients. As a leading patient-centric technology business, Outcomes connects pharmacies, payers and pharmaceutical companies through patient engagement solutions, tailored tools for the future of pharmacy and advanced workflow optimization.


These press releases may also interest you

at 20:00
Chainstack, a frontrunner among the top three global Web3 infrastructure providers, has successfully secured a strategic investment from SBI Ven Capital, Sygnum, Azimut Group, Unicorn Factory Ventures, and Ventech Ventures. This investment will...

at 19:07
In the news release, Tapinator Announces Q1 2024 Financial Results, issued 14-May-2024 by Tapinator, Inc. over PR Newswire, we are advised by the company that bullet point number four in the subheading should read "Adjusted EBITDA* Increases 15%...

at 19:06
Forum Mobility, a leading heavy-duty truck charging infrastructure provider, celebrated the groundbreaking of its new "FM Harbor" charging depot in the Port of Long Beach during an event on Wednesday. The facility will serve over 200 electric drayage...

at 19:05
The Charleston Digital Corridor is proud to welcome Fexillon, an innovative leader in digitising the built environment, to its esteemed community as the company establishes its US office in Charleston, South Carolina. This strategic collaboration...

at 18:56
Trees capture and store carbon from the atmosphere, improve air and water quality, make our urban spaces shadier, cooler and more enjoyable, and can provide new habitat for wildlife. To bring these benefits to Canadians, and to support good jobs for...

at 18:45
Amgen will host a webcasted call for the investment community at 1:00 p.m. PT on Monday, May 20, 2024 following the presentation of new data from TEZSPIRE® in chronic obstructive pulmonary disease (COPD) at the American Thoracic Society (ATS)...



News published on and distributed by: